A detailed history of Vital Stone Financial, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Vital Stone Financial, LLC holds 291 shares of GILD stock, worth $27,339. This represents 0.02% of its overall portfolio holdings.

Number of Shares
291
Previous 288 1.04%
Holding current value
$27,339
Previous $19,000 26.32%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$66.59 - $83.99 $199 - $251
3 Added 1.04%
291 $24,000
Q2 2024

Aug 07, 2024

BUY
$63.15 - $72.88 $189 - $218
3 Added 1.05%
288 $19,000
Q1 2024

May 06, 2024

BUY
$71.58 - $87.29 $214 - $261
3 Added 1.06%
285 $21,000
Q2 2023

Aug 21, 2023

BUY
$76.01 - $86.7 $21,434 - $24,449
282 New
282 $23,000
Q4 2022

Jan 30, 2023

BUY
$62.32 - $89.47 $17,574 - $25,230
282 New
282 $24 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Vital Stone Financial, LLC Portfolio

Follow Vital Stone Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vital Stone Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vital Stone Financial, LLC with notifications on news.